Glaxo's Fortax (ceftazidine)
Executive Summary
The injectable antibiotic was approved by FDA July 19 with a 1B classification, signifying a new molecular entity with modest therapeutic gain. "The Pink Sheet" (July 22, T&G-1) reported that it was given a 1A designation.